Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

NCT04065438 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Segmental Glomerulosclerosis

Interventions

DEVICE: LIPOSORBER® LA-15

Sponsor

Kaneka Medical America LLC